ACHV Achieve Life Sciences Inc.

+1.51  (+84%)
Previous Close 1.79
Open 2.78
Price To Book 1.56
Market Cap 22179640
Shares 6,721,103
Volume 68,784,138
Short Ratio
Av. Daily Volume 139,994

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b data due mid-2019.
Smoking cessation

Latest News

  1. Four Healthcare Stocks Looking to Close Out a Strong Week
  2. Achieve Life Sciences' stock rockets on heavy volume after update results of smoking-cessation drug trial
  3. Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting
  4. Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation
  5. 5 Top Rising P/E Stocks to Enjoy Solid Gains
  6. Achieve Announces Update on Cytisinicline Clinical Development Program
  7. highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals
  8. 5 Top-Ranked Rising P/E Stocks to Lure Investors
  9. Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update
  10. Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
  11. 3 Healthcare Stocks that Could Move on Industry Growth
  12. Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation
  13. Achieve Life Sciences Stock Will Probably Tumble Further
  14. Achieve Announces Pricing of $5.6 Million Registered Direct Offering
  15. Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects
  16. Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018
  17. Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy
  18. Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference
  19. Achieve to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018